Literature DB >> 25346250

The clinical significance of findings obtained on 3D-FLAIR MR imaging in patients with Ramsay-Hunt syndrome.

Mi S Chung1, Jeong H Lee, Dae Y Kim, Young-Min Lim, Joong H Ahn, Yu S Sung, Young J Choi, Ra G Yoon, Jung H Baek.   

Abstract

OBJECTIVES/HYPOTHESIS: To investigate the clinical significance of three-dimensional-fluid-attenuated inversion recovery (3D-FLAIR) magnetic resonance imaging (MRI) findings in patients with Ramsay-Hunt syndrome (RHS). STUDY
DESIGN: Case series.
METHODS: We enrolled 28 consecutive patients of RHS with temporal bone MRI. Initial clinical findings and outcome were assessed by House-Brackmann (HB) scales, electroneuronography (ENoG), and pure tone audiometry (PTA). Two radiologists evaluated the presence of abnormalities on pre-/postcontrast 3D-FLAIR for the cranial nerve (CN)-VII, CN-VIII, inner ear (IE), and the posterior fossa by consensus. The relative signal intensity and enhancement degree (rED) of the structures were measured using ImageJ (http://rsbweb.nih.gov/ij/). Statistical test correlated the clinical symptoms and the outcome with the analysis results of 3D-FLAIR images.
RESULTS: 3D-FLAIR demonstrated enhancement of CN-VII in all patients. Precontrast hyperintensity and enhancement were seen in eight and 16 patients with IE, and in four and six with CN-VIII, respectively. Precontrast hyperintensity of IE or CN-VIII was significantly associated with the presence of vertigo (P value < 0.05). Precontrast hyperintensity of IE or CN-VIII significantly correlated with clinical symptoms assessed by HB, ENoG, and PTA (P value < 0.05, respectively). rED of the vestibule moderately correlated with initial HB scale (r = 0.391, P = 0.039). There was no correlation between any of the 3D-FLAIR findings and the follow-up HB.
CONCLUSIONS: RHS shows frequent abnormalities of IE or CN-VIII, as well as CN-VII on pre-/postcontrast 3D-FLAIR images. Precontrast hyperintensity of IE/CN-VIII on 3D-FLAIR is significantly correlated with the severity of facial palsy, the presence of vertigo, and the degree of hearing impairment but not with clinical outcome.
© 2014 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  3D-FLAIR; MRI; Ramsay-Hunt Syndrome; facial palsy

Mesh:

Substances:

Year:  2014        PMID: 25346250     DOI: 10.1002/lary.24973

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  6 in total

1.  Superior vestibular neuritis: improved detection using FLAIR sequence with delayed enhancement (1 h).

Authors:  Aina Venkatasamy; Tri Thai Huynh; Nathan Wohlhuter; Hella Vuong; Dominique Rohmer; Anne Charpiot; Nicolas Meyer; Francis Veillon
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-09-17       Impact factor: 2.503

2.  Imaging of facial neuritis using T2-weighted gradient-echo fast imaging employing steady-state acquisition after gadolinium injection.

Authors:  Magali Hector; Ahmad Alnadji; Francis Veillon; Maher Abu Eid; Anne Charpiot; Christian Debry; Aïna Venkatasamy
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-09-22       Impact factor: 2.503

3.  Atypical clinical manifestations of herpes zoster oticus: diagnostic usefulness of magnetic resonance imaging.

Authors:  Jin Woo Choi; Hyunjoo Nahm; Jung Eun Shin; Chang-Hee Kim
Journal:  J Neurovirol       Date:  2019-07-05       Impact factor: 3.739

4.  Clinical Characteristics of Dizziness Associated with Acute Peripheral Facial Palsy.

Authors:  Kudamo Song; Sehun Chang; Jun Lee; Sun Ae Shin; Ho Yun Lee
Journal:  J Audiol Otol       Date:  2018-04-17

5.  Mastoid effusion on temporal bone MRI in patients with Bell's palsy and Ramsay Hunt syndrome.

Authors:  Jin Woo Choi; Jiyeon Lee; Dong-Han Lee; Jung Eun Shin; Chang-Hee Kim
Journal:  Sci Rep       Date:  2021-02-04       Impact factor: 4.379

6.  Signal intensity pattern of the normal oculomotor nerve on contrast-enhanced 3D FLAIR at 3.0 T MRI.

Authors:  Thiparom Sananmuang; Chanonporn Boonsiriwattanakul; Theeraphol Panyaping
Journal:  Neuroradiol J       Date:  2020-11-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.